Noninvasive ventilation in COVID-19 patients aged ≥ 70 years—a prospective multicentre cohort study
SOFA score
Clinical endpoint
DOI:
10.1186/s13054-022-04082-1
Publication Date:
2022-07-22T10:03:14Z
AUTHORS (171)
ABSTRACT
Abstract Background Noninvasive ventilation (NIV) is a promising alternative to invasive mechanical (IMV) with particular importance amidst the shortage of intensive care unit (ICU) beds during COVID-19 pandemic. We aimed evaluate use NIV in Europe and factors associated outcomes patients treated NIV. Methods This substudy COVIP study—an international prospective observational study enrolling aged ≥ 70 years confirmed ICU. enrolled 156 ICUs across 15 European countries between March 2020 April 2021.The primary endpoint was 30-day mortality. Results Cohort included 3074 patients, most whom were male (2197/3074, 71.4%) at mean age 75.7 (SD 4.6). frequency 25.7% varied from 1.1 62.0% participating countries. Primary failure, defined as need for endotracheal intubation or death within 30 days since ICU admission, occurred 470/629 (74.7%) patients. Factors increased failure risk higher Sequential Organ Failure Assessment (SOFA) score (OR 3.73, 95% CI 2.36–5.90) Clinical Frailty Scale (CFS) on admission 1.46, 1.06–2.00). Patients initially (n = 630) lived 1.36 fewer (95% − 2.27 0.46 days) compared IMV group 1876). Conclusions Frequency varies Higher severity illness more severe frailty among critically ill older adults COVID-19. better than Trial Registration NCT04321265 , registered 19 2020, https://clinicaltrials.gov .
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (30)
CITATIONS (16)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....